1986
DOI: 10.1159/000183975
|View full text |Cite
|
Sign up to set email alerts
|

Urinary Excretion of Hydroxylysine and Its Glycosides in Alport’s Syndrome and Several Other Glomerulopathies

Abstract: Alport’s syndrome probably is a molecular disorder of basement membrane composition. Investigation of urine on basement membrane components such as hydroxylysine and its glycosides, glucosylgalactosylhydroxylysine and galactosylhydroxylysine, may be helpful for diagnosis of the disease. Urinary specimens of 33 patients and 12 siblings were investigated, and the results were compared with those of 14 healthy adults and of 29 healthy children. The urine of patients with glomerulopathies, occurring during childho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1987
1987
1991
1991

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…In a former study, no marked differences in excretion rates of the free compounds between normals and pa tients suffering from Alport's syndrome could be estab lished [5], in contrast to data from the literature [2,3]. It was suggested in that study, that investigation of the peptide-bound fraction of urinary glycosides might be a better diagnostic approach of Alport's syndrome.…”
Section: Discussionmentioning
confidence: 78%
See 1 more Smart Citation
“…In a former study, no marked differences in excretion rates of the free compounds between normals and pa tients suffering from Alport's syndrome could be estab lished [5], in contrast to data from the literature [2,3]. It was suggested in that study, that investigation of the peptide-bound fraction of urinary glycosides might be a better diagnostic approach of Alport's syndrome.…”
Section: Discussionmentioning
confidence: 78%
“…Increased excretion rates of GGH and GH have been reported in this syndrome [2,3]. In a former study, however, we were unable to distinguish clearly Alport patients and patients with other glomeru lopathies from normals [4,5]. The investigation of peptide-bound hydroxylysylglycosides might be a more promising approach from a diagnostic point of view.…”
Section: Introductionmentioning
confidence: 84%